The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Letter to the EditorFull Access

Functionalizing Diagnostics

To the Editor: In his review of my book titled Pharmacotherapy for Mood, Anxiety, and Cognitive Disorders, edited by U. Halbreich and S.A. Montgomery, Donald F. Klein, M.D. (1), mentions my plea to “focus on the functional impairments” in psychiatric diagnosis and calls this approach “premature” (1, p. 166). By functionalization, I mean dissection of the psychiatric syndromes diagnosed in a given patient into their component parts, i.e., the psychopathological symptoms, followed by attempts to identify the psychic dysfunctions generating the phenomena that patients experience and observers register as psychopathological symptoms (2). The focus of biological psychiatry, we maintain, should be less on disease entities or syndromes than on exploring the neurobiological underpinnings of psychic (dys)functions (3).

“Van Praag,” Dr. Klein has it, “would have us give up the morass of comorbidly occurring syndromes and, in fact, the concept of disease entities to focus on the fundamental impairments that incur the psychopathological state” (1, p. 166)

This statement is only partly correct. I do see functionalization as an indispensable method for providing psychiatric diagnosis with a solid scientific bedrock. I have not suggested giving up syndromal and nosological diagnosis altogether but adding functionalization to the present diagnostic process (4).

Dr. Klein continues: “If we knew the brain functions that allow us to cogitate, emote, and behave, then Van Praag’s suggestion would resonate” (1, p. 166), but at present a functional psychopathological approach seems to him premature.

I disagree with him. If we ever want to know the “brain functions that allow us to cogitate, emote, and behave,” we first have to characterize the psychic dysfunctions that generate psychopathology. Systematic attempts to functionalize psychiatric diagnosing seem to me not premature but long overdue.

References

1. Klein DF: Book review, U Halbreich, SA Montgomery (eds): Pharmacotherapy for Mood, Anxiety, and Cognitive Disorders. Am J Psychiatry 2002; 159:165–166LinkGoogle Scholar

2. Van Praag HM, Leijnse B: Neubewertung des Syndroms: Skizze einer funktionellen Pathologie. Psychiatr Neurol Neurochir 1965; 68:50–66MedlineGoogle Scholar

3. Van Praag HM: Nosologomania: a disorder of psychiatry. World J Biol Psychiatry 2000; 1:151–158Crossref, MedlineGoogle Scholar

4. Van Praag HM: Over the mainstream: diagnostic requirements for biological psychiatric research. Psychiatry Res 1997; 72:201–212Crossref, MedlineGoogle Scholar